<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药事纵横 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-24T07:35:20+08:00</updated>
  <subtitle>药事纵横是一个由多位制药精英联合创办的媒体平台，旨在分享与传递药品研发、生产和注册中所涉及的技术、经验和情报，欢迎关注和投稿！投稿请发442015666@qq.com</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>“假”多晶型“真”的有用—溶剂化物晶型分类及应用</title>
    <updated>2020-12-23T22:24:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/eL193uiDofx_jX4H2YFG0w</id>
    <link href="https://mp.weixin.qq.com/s/eL193uiDofx_jX4H2YFG0w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>小妙招：高速剪切粉末预测粘冲技巧</title>
    <updated>2020-12-23T22:24:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/7a2dMIN3-jqchBrwT5JPbA</id>
    <link href="https://mp.weixin.qq.com/s/7a2dMIN3-jqchBrwT5JPbA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>色谱柱应用案例</title>
    <updated>2020-12-23T22:24:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/OWJARZzyQ86d4rRfsxiqSw</id>
    <link href="https://mp.weixin.qq.com/s/OWJARZzyQ86d4rRfsxiqSw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>东阳光的丙肝新药依米他韦获NMPA批准上市</title>
    <updated>2020-12-23T22:24:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/lh1iUEGmBKHm23h0DiirqA</id>
    <link href="https://mp.weixin.qq.com/s/lh1iUEGmBKHm23h0DiirqA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>HPLC与HPLC/UHPLC/UPLC之间方法的等效转换策略</title>
    <updated>2020-12-22T22:00:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/L0SSc5ipFRK7iMp6xe4Kjw</id>
    <link href="https://mp.weixin.qq.com/s/L0SSc5ipFRK7iMp6xe4Kjw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA批准第49个新药，用于HER2阳性乳腺癌三线治疗</title>
    <updated>2020-12-22T22:00:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/nqBq2C1N__VGUK1w1ruakg</id>
    <link href="https://mp.weixin.qq.com/s/nqBq2C1N__VGUK1w1ruakg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>明胶胶囊交联问题的研究思路</title>
    <updated>2020-12-22T22:00:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/yasKJ6D3eABqiwHZBKIfQg</id>
    <link href="https://mp.weixin.qq.com/s/yasKJ6D3eABqiwHZBKIfQg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>人人学懂免疫学：第十五期</title>
    <updated>2020-12-22T22:00:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/E1LwxvH_3iJl6Yc-Pu4fIw</id>
    <link href="https://mp.weixin.qq.com/s/E1LwxvH_3iJl6Yc-Pu4fIw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>为什么HPMCAS被广泛用于喷雾干燥分散体SDD的设计？</title>
    <updated>2020-12-21T19:11:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/WcCuC1AEgv7cL-LDcgL_JQ</id>
    <link href="https://mp.weixin.qq.com/s/WcCuC1AEgv7cL-LDcgL_JQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>韩国特应性皮炎新药寻求中国合作伙伴</title>
    <updated>2020-12-21T19:11:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/LzMOxbhI1dbex0fcXqF8pA</id>
    <link href="https://mp.weixin.qq.com/s/LzMOxbhI1dbex0fcXqF8pA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球11月批准的新药</title>
    <updated>2020-12-21T19:11:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/fpixRFQLnIuCfv3lwdwzUg</id>
    <link href="https://mp.weixin.qq.com/s/fpixRFQLnIuCfv3lwdwzUg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药物共晶及其表征方法</title>
    <updated>2020-12-21T19:11:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/V4fB8sViang37eTO1WxNZw</id>
    <link href="https://mp.weixin.qq.com/s/V4fB8sViang37eTO1WxNZw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“替代对照品法”在有关物质测定中的应用</title>
    <updated>2020-12-20T17:07:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/RWnISGWMZ2bJ5kPXkt-dzg</id>
    <link href="https://mp.weixin.qq.com/s/RWnISGWMZ2bJ5kPXkt-dzg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【12-26北京见】药品上市后变更技术研究、申报策略及M4申报资料撰写专题培训</title>
    <updated>2020-12-20T17:07:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/X5ugcWmxgrr0aQIjAkC58g</id>
    <link href="https://mp.weixin.qq.com/s/X5ugcWmxgrr0aQIjAkC58g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>我姓“炎”</title>
    <updated>2020-12-20T17:07:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/6tYtMiMdy-rUiOahDWPLTg</id>
    <link href="https://mp.weixin.qq.com/s/6tYtMiMdy-rUiOahDWPLTg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>仿制原料药小试开发合成与分析该如何做</title>
    <updated>2020-12-20T17:07:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/MTqrGmNlpY8rDPGFYyL59w</id>
    <link href="https://mp.weixin.qq.com/s/MTqrGmNlpY8rDPGFYyL59w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA批准新型口服GnRH受体阻断剂用于前列腺癌治疗</title>
    <updated>2020-12-20T10:37:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/IZ-rdT-zs8_22V7NFct-rg</id>
    <link href="https://mp.weixin.qq.com/s/IZ-rdT-zs8_22V7NFct-rg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>TAGRISSO®:FDA批准了最常见类型肺癌的首个辅助疗法</title>
    <updated>2020-12-20T10:37:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/vHHOHvcdGkWV8wO8iiZLUw</id>
    <link href="https://mp.weixin.qq.com/s/vHHOHvcdGkWV8wO8iiZLUw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年最后一次开放加群，有加群需求而未进群的朋友抓住机会</title>
    <updated>2020-12-20T10:37:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/NGifAS9KGXXz9YtnABT5HQ</id>
    <link href="https://mp.weixin.qq.com/s/NGifAS9KGXXz9YtnABT5HQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>颠覆式创新：小分子PD-L1抑制剂能否破解PPI靶点成药难题？</title>
    <updated>2020-12-19T23:19:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/ZgZ5u_XOSb3jAK8jCB5L7A</id>
    <link href="https://mp.weixin.qq.com/s/ZgZ5u_XOSb3jAK8jCB5L7A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>